- Home
- PLX vs LWLG Comparison
PLX vs LWLG Comparison
Compare PLX & LWLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLX
- LWLG
- Stock Information
- Founded
- PLX 1993
- LWLG 1991
- Country
- PLX United States
- LWLG United States
- Employees
- PLX N/A
- LWLG N/A
- Industry
- PLX Biotechnology: Biological Products (No Diagnostic Substances)
- LWLG Containers/Packaging
- Sector
- PLX Health Care
- LWLG Industrials
- Exchange
- PLX Nasdaq
- LWLG Nasdaq
- Market Cap
- PLX 122.6M
- LWLG 126.0M
- IPO Year
- PLX 1998
- LWLG N/A
- Fundamental
- Price
- PLX $1.37
- LWLG $1.43
- Analyst Decision
- PLX Strong Buy
- LWLG
- Analyst Count
- PLX 1
- LWLG 0
- Target Price
- PLX $15.00
- LWLG N/A
- AVG Volume (30 Days)
- PLX 1.3M
- LWLG 1.8M
- Earning Date
- PLX 08-13-2025
- LWLG 08-08-2025
- Dividend Yield
- PLX N/A
- LWLG N/A
- EPS Growth
- PLX N/A
- LWLG N/A
- EPS
- PLX 0.05
- LWLG N/A
- Revenue
- PLX $59,764,000.00
- LWLG $88,105.00
- Revenue This Year
- PLX $65.02
- LWLG N/A
- Revenue Next Year
- PLX $57.34
- LWLG N/A
- P/E Ratio
- PLX $28.34
- LWLG N/A
- Revenue Growth
- PLX 0.18
- LWLG 24.23
- 52 Week Low
- PLX $0.82
- LWLG $0.79
- 52 Week High
- PLX $3.10
- LWLG $4.23
- Technical
- Relative Strength Index (RSI)
- PLX 41.78
- LWLG 61.13
- Support Level
- PLX $1.43
- LWLG $1.22
- Resistance Level
- PLX $1.54
- LWLG $1.56
- Average True Range (ATR)
- PLX 0.09
- LWLG 0.09
- MACD
- PLX 0.01
- LWLG 0.01
- Stochastic Oscillator
- PLX 5.77
- LWLG 64.86
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.
About LWLG Lightwave Logic Inc.
Lightwave Logic Inc is a United States-based development stage company moving toward commercialization of next-generation electro-optic photonic devices made on its P2IC technology platform which uses in-house proprietary high-activity and high-stability organic polymers. Electro-optical devices convert data from electric signals into optical signals for multiple applications. It designs and synthesizes organic chromophores for use in its own proprietary electro-optic polymer systems and photonic device designs.